These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 39309418
1. Analysis of bone single-photon emission CT/CT and diffusion-weighted MR imaging in medication-related osteonecrosis of the jaw: focusing on the correlation between standardized uptake values and apparent diffusion coefficient values. Tezuka Y, Ogura I. Am J Nucl Med Mol Imaging; 2024; 14(4):230-238. PubMed ID: 39309418 [Abstract] [Full Text] [Related]
4. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value. Ogawa R, Ogura I. Dentomaxillofac Radiol; 2021 Dec 01; 50(8):20200516. PubMed ID: 34019434 [Abstract] [Full Text] [Related]
5. Evaluation of jaw pathologies of patients with medication-related osteonecrosis of the jaw using a computer program to assess the bone scan index: comparison of standardized uptake values with bone SPECT/CT. Shirai A, Ogura I. Nucl Med Commun; 2024 Dec 01; 45(12):1007-1012. PubMed ID: 39262375 [Abstract] [Full Text] [Related]
6. The value of diffusion-weighted imaging in the diagnosis of medication-related osteonecrosis of the jaws. Muraoka H, Ito K, Hirahara N, Okada S, Kondo T, Kaneda T. Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Sep 01; 132(3):339-345. PubMed ID: 34092542 [Abstract] [Full Text] [Related]
7. Tc-99m hydroxymethylene diphosphonate scintigraphy, computed tomography, and magnetic resonance imaging of osteonecrosis in the mandible: Osteoradionecrosis versus medication-related osteonecrosis of the jaw. Ogura I, Sasaki Y, Sue M, Oda T, Kameta A, Hayama K. Imaging Sci Dent; 2019 Mar 01; 49(1):53-58. PubMed ID: 30941288 [Abstract] [Full Text] [Related]
8. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw. Minami Y, Ogura I. J Med Imaging Radiat Oncol; 2021 Apr 01; 65(2):160-165. PubMed ID: 33180378 [Abstract] [Full Text] [Related]
9. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value. Toshima H, Ogura I. Dentomaxillofac Radiol; 2020 Dec 01; 49(8):20200043. PubMed ID: 32491931 [Abstract] [Full Text] [Related]
10. Visualising cervical lymph nodes in jaw osteonecrosis using diffusion-weighted imaging. Muraoka H, Kaneda T, Kondo T, Otsuka K, Tokunaga S. Oral Dis; 2024 Nov 01; 30(8):5154-5159. PubMed ID: 38515001 [Abstract] [Full Text] [Related]
11. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis. Ogura I, Kobayashi E, Nakahara K, Igarashi K, Haga-Tsujimura M, Toshima H. Ann Nucl Med; 2019 Oct 01; 33(10):776-782. PubMed ID: 31342316 [Abstract] [Full Text] [Related]
12. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings. Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K. Jpn J Radiol; 2022 May 01; 40(5):492-499. PubMed ID: 34851501 [Abstract] [Full Text] [Related]
13. Evaluation of Three Imaging Methods to Quantify Key Events in Pelvic Bone Metastasis. Lee H, Ahn TR, Hwang KH, Lee SW. Cancers (Basel); 2024 Jan 02; 16(1):. PubMed ID: 38201641 [Abstract] [Full Text] [Related]
14. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response. Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K. Jpn J Radiol; 2023 Jul 02; 41(7):760-767. PubMed ID: 36656541 [Abstract] [Full Text] [Related]
15. Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging. Miyashita H, Kameyama K, Morita M, Nakagawa T, Nakahara T. Dentomaxillofac Radiol; 2019 Dec 02; 48(8):20190208. PubMed ID: 31287720 [Abstract] [Full Text] [Related]
16. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF. Invest Radiol; 2013 May 02; 48(5):247-55. PubMed ID: 23519008 [Abstract] [Full Text] [Related]
17. Comparison of single photon emission computed tomography-computed tomography, computed tomography and magnetic resonance imaging of medication-related osteonecrosis of jaw by new calculated parameters. Minami Y, Ogura I. Q J Nucl Med Mol Imaging; 2024 Jun 02; 68(2):126-132. PubMed ID: 36287042 [Abstract] [Full Text] [Related]
18. Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values. Lee SY, Jee WH, Yoo IR, Jung JY, Im SA, Chung YG, Kang JH. Br J Radiol; 2019 Oct 02; 92(1102):20181051. PubMed ID: 31322913 [Abstract] [Full Text] [Related]
19. Quantitative assessment of mandibular bone marrow using computed tomography texture analysis for detect stage 0 medication-related osteonecrosis of the jaw. Ito K, Muraoka H, Hirahara N, Sawada E, Hirohata S, Otsuka K, Okada S, Kaneda T. Eur J Radiol; 2021 Dec 02; 145():110030. PubMed ID: 34798536 [Abstract] [Full Text] [Related]
20. Correlation Between Apparent Diffusion Coefficients and Standardized Uptake Values in Hybrid (18)F-FDG PET/MR: Preliminary Results in Rectal Cancer. Jeong JH, Cho IH, Chun KA, Kong EJ, Kwon SD, Kim JH. Nucl Med Mol Imaging; 2016 Jun 02; 50(2):150-6. PubMed ID: 27275364 [Abstract] [Full Text] [Related] Page: [Next] [New Search]